Business
REDS: Q2 sales fell 28% but H1 sales grew 6% year-over-year, with strong cash and new product launches
REDS: Q2 sales fell 28% but H1 sales grew 6% year-over-year, with strong cash and new product launches
About this update from Redsense Medical Ab
Net sales declined 28% in Q2 2025, but H1 sales rose 6% year-over-year, with the US market contributing 99% of sales. The Redsense Clamp was CE marked and launched in new markets, while currency volatility and increased tariffs posed risks. Cash position remained strong at KSEK 14,692.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
View stock analysis, news, and events for Redsense Medical Ab